SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The outcome of donor screening for Human T‐Cell Lymphotropic Virus infection in the Netherlands
2 references·1 citing·9 second hop
The outcome of donor screening for Human T‐Cell Lymphotropic Virus infection in the Netherlands (2011)The outcome of donor screening for Human …Blood safety strategies for human T‐cell lymphotropic virus in Europe (2008)Blood safety strategies for h…Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis (1998)Screening for human T cell le…Human T‐cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada (2018)Human T‐cell lymphotropic vir…Transmission of Retroviruses from Seronegative Donors by Transfusion during Cardiac Surgery (1992)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Human T‐lymphotropic virus antibody screening of blood donors: rates of false‐positive results and evaluation of a potential donor reentry algorithm (2010)Surveillance of Transfusion-Transmissible Infections (2011)Reconsideration of blood donation testing strategy for human T‐cell lymphotropic virus in Australia (2017)Health economic implications of testing blood donors in South Africa for HTLV 1 & 2 infection (2019)Bullying in school: are short pupils at risk? Questionnaire study in a cohort (2000)False‐reactive microbiologic screening test results in Swedish blood donors—how big is the problem? A survey among blood centers and deferred donors (2006)Cost‐effectiveness of additional blood screening tests in the Netherlands (2011)
this work references cited by second hop

References

  • 2008Blood safety strategies for human T‐cell lymphotropic virus in Europe75 cited
  • 1998Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis41 cited

Cited by

  • 2018Human T‐cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada13 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work